Ετικέτες

Κυριακή 3 Δεκεμβρίου 2017

Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab

Abstract

An increased expression of interleukin-23 has been observed in patients with pyoderma gangrenosum, leading to the use of ustekinumab as a therapeutic option. We report the successful use of ustekinumab in three patients with treatment-resistant pyoderma gangrenosum of varying clinical presentations.



http://ift.tt/2iIyMBp

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου